GGHC
GWPH

Gilder Gagnon Howe & Co’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,864
Closed -$494K – 310
2019
Q2 		$494K Buy
+2,864
New +$495K 0.01% 245

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Gilder Gagnon Howe & Co's GWPH Position: Q3 2019 in Review

Gilder Gagnon Howe & Co sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2019, closing a stake of 2,864 shares — an estimated $494K sold.

Gilder Gagnon Howe & Co first reported a position in GWPH in Q2 2019 and held it in 1 quarter. The position peaked at $494K in Q2 2019. 316 funds tracked by Wall St. Rank hold GWPH as of Q3 2019.

  • Gilder Gagnon Howe & Co reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2019 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 2,864 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2019, an estimated $494K.
  • Gilder Gagnon Howe & Co first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2019 and held it in 1 quarter.
  • Gilder Gagnon Howe & Co's GW Pharmaceuticals Plc American Depositary Shares position peaked at $494K in Q2 2019.
  • 316 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2019.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2019, filed 14 Nov 2019.